Literature DB >> 26320250

Endocannabinoid System Contributes to Liver Injury and Inflammation by Activation of Bone Marrow-Derived Monocytes/Macrophages in a CB1-Dependent Manner.

Ping Mai1, Le Yang1, Lei Tian1, Lin Wang1, Shuangshuang Jia1, Yuanyuan Zhang1, Xin Liu1, Lin Yang1, Liying Li2.   

Abstract

Hepatic injury undergoes significant increases in endocannabinoidsand infiltrations of macrophages, yet the concrete mechanisms of changes in endocannabinoids and the functions of macrophage-expressed cannabinoid receptors (CBs) are unclear. Biosynthetic and degradative enzymes of endocannabinoids revealed a significant change in human fibrotic liver. Meanwhile, we showed dynamic changes of these enzymes and CBs (CB1 and CB2) from 1 to 56 d in carbon tetrachloride-induced murine liver injury. Biosynthetic enzymes (N-acylphosphatidyl-ethanolamine selective phospholipase D and diacylglycerol lipase-α) and CBs were markedly increased, whereas degradative enzymes (fatty acid amidohydrolase and monoacylglycerol lipase) were downregulated. Moreover, these enzymes intimately correlated with the fibrosis parameter [procollagen α1(III)]. Bone marrow-derived monocytes/macrophages (BMM) expressed CBs. Interestingly, CB1 but not CB2 mediated BMM migration through a Boyden chambers assay, and the effect depended on the G(α)i/o/RhoA/ROCK signaling pathway. ICR mice were lethally irradiated and received BM transplants from enhanced GFP transgenic mice. Four weeks later, mice of BM reconstruction were subjected to carbon tetrachloride-induced liver injury. In the chimeric murine model, we found that blockade of CB1 by administration of a CB1 antagonist inhibited the recruitment of BMM into injured liver using immunofluorescence staining and FACS, but it did not have effects on migration of T cells and dendritic cells without CB1 expression. Furthermore, activation of CB1 enhanced cytokine expression of BMM. In vivo, inhibition of CB1 attenuated the inflammatory cytokine level through real-time RT-PCR and cytometric bead array, ameliorating hepatic inflammation and fibrosis. In this study, we identify inactivation of BMM-expressed CB1 as a therapeutic strategy for reducing hepatic inflammation and fibrosis.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26320250     DOI: 10.4049/jimmunol.1403205

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

Review 1.  Myeloid Cells and Chronic Liver Disease: a Comprehensive Review.

Authors:  Min Lian; Carlo Selmi; M Eric Gershwin; Xiong Ma
Journal:  Clin Rev Allergy Immunol       Date:  2018-04       Impact factor: 8.667

2.  Differential hepatoprotective role of the cannabinoid CB1 and CB2 receptors in paracetamol-induced liver injury.

Authors:  Patricia Rivera; Antonio Vargas; Antoni Pastor; Anna Boronat; Antonio Jesús López-Gambero; Laura Sánchez-Marín; Dina Medina-Vera; Antonia Serrano; Francisco Javier Pavón; Rafael de la Torre; Ekaitz Agirregoitia; María Isabel Lucena; Fernando Rodríguez de Fonseca; Juan Decara; Juan Suárez
Journal:  Br J Pharmacol       Date:  2020-04-15       Impact factor: 8.739

3.  The class D scavenger receptor CD68 contributes to mouse chronic liver injury.

Authors:  Le Yang; Lin Yang; Chengbin Dong; Liying Li
Journal:  Immunol Res       Date:  2018-06       Impact factor: 2.829

4.  Cannabinoid CB1 receptor gene inactivation in oligodendrocyte precursors disrupts oligodendrogenesis and myelination in mice.

Authors:  Aníbal Sánchez-de la Torre; Tania Aguado; Alba Huerga-Gómez; Silvia Santamaría; Antonietta Gentile; Juan Carlos Chara; Carlos Matute; Krisztina Monory; Susana Mato; Manuel Guzmán; Beat Lutz; Ismael Galve-Roperh; Javier Palazuelos
Journal:  Cell Death Dis       Date:  2022-07-07       Impact factor: 9.685

Review 5.  The Endocannabinoid Signaling System in the CNS: A Primer.

Authors:  Cecilia J Hillard
Journal:  Int Rev Neurobiol       Date:  2015-11-06       Impact factor: 3.230

6.  Macrophage Migration Inhibitor Factor Upregulates MCP-1 Expression in an Autocrine Manner in Hepatocytes during Acute Mouse Liver Injury.

Authors:  Jieshi Xie; Le Yang; Lei Tian; Weiyang Li; Lin Yang; Liying Li
Journal:  Sci Rep       Date:  2016-06-08       Impact factor: 4.379

7.  Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight loss.

Authors:  Alison J Dawson; Eric S Kilpatrick; Anne-Marie Coady; Abeer M M Elshewehy; Youssra Dakroury; Lina Ahmed; Stephen L Atkin; Thozhukat Sathyapalan
Journal:  BMC Endocr Disord       Date:  2017-07-14       Impact factor: 2.763

8.  The cannabinoid ligand LH-21 reduces anxiety and improves glucose handling in diet-induced obese pre-diabetic mice.

Authors:  Silvana Y Romero-Zerbo; Inmaculada Ruz-Maldonado; Vanesa Espinosa-Jiménez; Alex Rafacho; Ana I Gómez-Conde; Lourdes Sánchez-Salido; Nadia Cobo-Vuilleumier; Benoit R Gauthier; Francisco J Tinahones; Shanta J Persaud; Francisco J Bermúdez-Silva
Journal:  Sci Rep       Date:  2017-06-21       Impact factor: 4.379

9.  Cannabinoid Receptor 1 Participates in Liver Inflammation by Promoting M1 Macrophage Polarization via RhoA/NF-κB p65 and ERK1/2 Pathways, Respectively, in Mouse Liver Fibrogenesis.

Authors:  Lei Tian; Weiyang Li; Le Yang; Na Chang; Xiaoting Fan; Xiaofang Ji; Jieshi Xie; Lin Yang; Liying Li
Journal:  Front Immunol       Date:  2017-09-28       Impact factor: 7.561

10.  Identification of novel mouse and rat CB1R isoforms and in silico modeling of human CB1R for peripheral cannabinoid therapeutics.

Authors:  Qing-Rong Liu; Nicholas S Huang; Hong Qu; Jennifer F O'Connell; Isabel Gonzalez-Mariscal; Sara Santa-Cruz-Calvo; Maire E Doyle; Zheng-Xiong Xi; Yun Wang; Emmanuel S Onaivi; Josephine M Egan
Journal:  Acta Pharmacol Sin       Date:  2018-09-10       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.